Scripps Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Scripps Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012218
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scripps Health (Scripps) is a non-profit healthcare organization, which provides healthcare services including primary care and urgent and emergency care services; preventive services and wellness screening services in San Diego County in the US. Scripps offers specialized medical care with medical departments in most of the major medical and surgical specialties. It operates major acute care facilities in its campuses including Scripps Green Hospital; Scripps Memorial Hospital Encinitas and La Jolla; and Scripps Mercy Hospital. It has a network of integrated facilities, outpatient centers and clinics under Scripps Clinic and Scripps Coastal Medical Center. It also operates Prebys Cardiovascular Institute for heart care. It also offers Scripps Home Health Care services, Scripps Hospice and a range of health education classes and support services. Scripps is headquartered in San Diego, California, the US.

Scripps Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scripps Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scripps Health, Medical Devices Deals, 2011 to YTD 2017 8
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scripps Health, Pharmaceuticals & Healthcare, Deal Details 10
Debt Offering 10
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2032 For US$21.7 Million 10
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2040 For US$80 Million 11
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2035 For US$35.7 Million 12
Scripps Health Completes Public Offering Of Bonds Due 2021 For US$2.2 Million 13
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2022 For US$1.7 Million 14
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2023 For US$3.8 Million 15
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2024 For US$5.3 Million 16
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2025 For US$5.4 Million 17
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2026 For US$5.6 Million 18
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2027 For US$5.8 Million 19
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2028 For US$4.3 Million 20
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2029 For US$4.5 Million 21
Acquisition 22
Scripps Health Plans To Acquire El Centro Regional Medical Center 22
Scripps Health – Key Competitors 23
Scripps Health – Key Employees 24
Scripps Health – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
May 25, 2016: Proton Therapy Opens Unique Window on Cancer Research 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Scripps Health, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Scripps Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scripps Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scripps Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scripps Health, Medical Devices Deals, 2011 to YTD 2017 8
Scripps Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2032 For US$21.7 Million 10
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2040 For US$80 Million 11
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2035 For US$35.7 Million 12
Scripps Health Completes Public Offering Of Bonds Due 2021 For US$2.2 Million 13
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2022 For US$1.7 Million 14
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2023 For US$3.8 Million 15
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2024 For US$5.3 Million 16
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2025 For US$5.4 Million 17
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2026 For US$5.6 Million 18
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2027 For US$5.8 Million 19
Scripps Health Completes Public Offering Of Series 2012A Bonds Due 2028 For US$4.3 Million 20
Scripps Health Completes Debt Offering Of Series 2012A Bonds Due 2029 For US$4.5 Million 21
Scripps Health Plans To Acquire El Centro Regional Medical Center 22
Scripps Health, Key Competitors 23
Scripps Health, Key Employees 24
Scripps Health, Other Locations 25
Scripps Health, Subsidiaries 26

★海外企業調査レポート[Scripps Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ABO Wind AG-エネルギー分野:企業M&A・提携分析
    Summary ABO Wind AG (ABO Wind) develops renewable energy projects in Europe. The company carries out the planning and environmental impact assessment, design, development, and operation of wind power projects and biomass power generating facilities. ABO Wind also provides long-term management or mai …
  • Superdry Plc:企業の戦略・SWOT・財務分析
    Superdry Plc - Strategy, SWOT and Corporate Finance Report Summary Superdry Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Microsoft Corporation:企業のM&A・事業提携・投資動向
    Microsoft Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microsoft Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Tilaknagar Industries Ltd.:企業の戦略・SWOT・財務情報
    Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oil Refineries Ltd (ORL):企業の財務・戦略的SWOT分析
    Oil Refineries Ltd (ORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Papa John’s International, Inc.:戦略・SWOT・企業財務分析
    Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioTime Inc (BTX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Lennar Corp:企業の戦略・SWOT・財務情報
    Lennar Corp - Strategy, SWOT and Corporate Finance Report Summary Lennar Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CloudFlare Inc (NET):企業の財務・戦略的SWOT分析
    CloudFlare Inc (NET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Leica Biosystems Nussloch GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Leica Biosystems Nussloch Gmbh (Leica Biosystems) is a medical device company. The company provides histology and anatomical pathology workflow solutions. It offers histology equipment and consumables; immuo histochemistry, in situ hybridization, and fluorescence in situ hybridization (FISH) …
  • Orion Diagnostica Oy:医療機器:M&Aディール及び事業提携情報
    Summary Orion Diagnostica Oy (Orion Diagnostica), a subsidiary of Orion Oyj, is a medical equipment company that develops, manufactures clinical diagnostic and hygiene monitoring tests. Its product portfolio provides diagnosis and treatment management kits, point of care systems, ready to use kits, …
  • Bachmann electronic GmbH:企業の戦略的SWOT分析
    Bachmann electronic GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Trane Inc:企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • HoMedics LLC:企業の戦略的SWOT分析
    HoMedics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential curr …
  • Vail Resorts Inc:戦略・SWOT・企業財務分析
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • IntriCon Corp (IIN):医療機器:M&Aディール及び事業提携情報
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • Solaria Energia y Medio Ambiente S.A. (SLR):電力:M&Aディール及び事業提携情報
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …
  • National Fertilizers Ltd (NFL):企業の財務・戦略的SWOT分析
    Summary National Fertilizers Ltd (NFL) is a chemical company that develops, manufactures and markets urea, bio-fertilizers and other industrial products. The company’s bio-fertilizers comprise phosphorous bio-fertilizers and nitrogenbio-fertilizers. Its industrial products include ammonium nitrate, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆